2012
DOI: 10.2215/cjn.03150312
|View full text |Cite
|
Sign up to set email alerts
|

Onco-Nephrology

Abstract: SummaryTumor lysis syndrome (TLS) describes the clinical and laboratory sequelae that result from the rapid release of intracellular contents of dying cancer cells. It is characterized by the release of potassium, phosphorous, and nucleic acids from cancer cells into the blood stream, with the potential to cause hyperkalemia; hyperphosphatemia and secondary hypocalcemia; hyperuricemia; AKI; and, should usual homeostatic mechanisms fail, death. TLS most commonly follows treatment of hematologic malignancies, su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
92
0
11

Year Published

2013
2013
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 119 publications
(103 citation statements)
references
References 92 publications
0
92
0
11
Order By: Relevance
“…Treatment of hyperkalemia in the emergency setting includes administration of potassium-binding agents (eg, Kayexalate) and hemodialysis. 6,7 Hyperphosphatemia is also commonly seen because malignant hematologic cells may contain up to 4 times more intracellular phosphate compared with normal mature lymphoid cells, and high cell turnover results in hyperphosphatemia as the serum concentration of phosphate exceeds the renal excretion threshold. Precipitation of calcium phosphate in the renal tubules subsequently results in hypocalcemia.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment of hyperkalemia in the emergency setting includes administration of potassium-binding agents (eg, Kayexalate) and hemodialysis. 6,7 Hyperphosphatemia is also commonly seen because malignant hematologic cells may contain up to 4 times more intracellular phosphate compared with normal mature lymphoid cells, and high cell turnover results in hyperphosphatemia as the serum concentration of phosphate exceeds the renal excretion threshold. Precipitation of calcium phosphate in the renal tubules subsequently results in hypocalcemia.…”
Section: Discussionmentioning
confidence: 99%
“…Intracellular phosphorous concentrations are high especially in Burkitt's lymphoma and B-cell acute lymphoblastic leukemia, with the incidences of TLS being previously reported as 14.9% and 26.4%, respectively [5]. Darmon et al reported that serum phosphate levels, the tumor burden as assessed by LHD and DIC, were associated with clinical TLS, and a 1 mmol increase in serum phosphate levels was associated with a 5-fold increase in the risk of clinical TLS [1].…”
Section: Discussionmentioning
confidence: 99%
“…The treatment consists of aggressive hydration, correction of electrolyte disturbances and uric acid-lowering therapy. If dialysis is required, continuous modalities may be favored, particularly in patients with more severe TLS [11]. Continuous therapies did not perform due to unavailable solutions.…”
Section: Discussionmentioning
confidence: 99%